Whole Foods Market vs Kenvue

Side-by-side comparison of AI visibility scores, market position, and capabilities

Kenvue leads in AI visibility (94 vs 69)
Whole Foods Market logo

Whole Foods Market

ChallengerRetail

Grocery

Whole Foods Market generates ~$22B in estimated annual revenue as Amazon's premium grocery chain. 530+ US/UK stores. Acquired by Amazon (AMZN) in 2017 for $13.7B. HQ: Austin, TX.

AI VisibilityBeta
Overall Score
B69
Category Rank
#6 of 9
AI Consensus
48%
Trend
down
Per Platform
ChatGPT
79
Perplexity
60
Gemini
80

About

Whole Foods Market is a leading American premium natural and organic grocery chain, founded in 1980 in Austin, Texas by John Mackey and Renée Lawson Hardy. The company pioneered the mainstreaming of natural and organic foods in the United States and redefined the grocery experience with its emphasis on health, sustainability, and local sourcing.

Full profile
Kenvue logo

Kenvue

LeaderConsumer Goods

Enterprise

Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.

AI VisibilityBeta
Overall Score
A94
Category Rank
#31 of 290
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
91
Perplexity
99
Gemini
89

About

Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).

Full profile

AI Visibility Head-to-Head

69
Overall Score
94
#6
Category Rank
#31
48
AI Consensus
70
down
Trend
stable
79
ChatGPT
91
60
Perplexity
99
80
Gemini
89
80
Claude
93
72
Grok
86

Key Details

Category
Grocery
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Whole Foods Market
Grocery
Kenvue is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.